- Home
- SKIN vs INO Comparison
SKIN vs INO Comparison
Compare SKIN & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKIN | INO |
|---|---|---|
| Founded | 1997 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.9M | 118.9M |
| IPO Year | 2020 | 1999 |
Fundamental Metrics
Financial Performance| Metric | SKIN | INO |
|---|---|---|
| Price | $1.04 | $1.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $2.00 | ★ $9.00 |
| AVG Volume (30 Days) | 610.2K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.63 | 35.14 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $334,294,000.00 | $42,220,086.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.42 | $23,060.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $0.78 | $1.30 |
| 52 Week High | $2.69 | $2.86 |
Technical Indicators
Market Signals| Indicator | SKIN | INO |
|---|---|---|
| Relative Strength Index (RSI) | 37.53 | 56.73 |
| Support Level | N/A | $1.70 |
| Resistance Level | $1.69 | $2.11 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 39.82 | 51.64 |
Price Performance
Historical ComparisonAbout SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.